Fig. 1From: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancerCONSORT Diagram: NSABP FB-7 studyBack to article page